CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images/2506/if_selected_60x60.jpg) | | ![](/images/10592/26062_A_7_6_rna_selected_60x60.jpg) | Expressed in all |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/19/ihc_cell_selected_60x60.jpg) | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25368/56075_B_1_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/2507/6518_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images/61418/if_selected_60x60.jpg) | | ![](/images/28900/64793_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | ![](/images/41454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2509/6584_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/37756/ihc_cell_selected_60x60.jpg) | ![](/images/12/106_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4353/13280_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | ![](/images/2490/6649_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CD93 | CD93 molecule | CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/12368/29566_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/13707/if_selected_60x60.jpg) | | ![](/images/13707/30523_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/20/if_selected_60x60.jpg) | | ![](/images/20/1352_B_5_4_rna_selected_60x60.jpg) | Expressed in all |
CDCP1 | CUB domain containing protein 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10979/28104_B_1_7_rna_selected_60x60.jpg) | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/4812/15140_B_9_7_rna_selected_60x60.jpg) | Mixed |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/58574/142433_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2146/5909_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11041/27138_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33689/80801_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/42455/if_selected_60x60.jpg) | ![](/images/2491/ihc_cell_selected_60x60.jpg) | ![](/images/2491/6134_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2659/ihc_cell_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17116/37868_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45942/139631_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
DARC | Duffy blood group, atypical chemokine receptor | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17672/41563_B_8_2_rna_selected_60x60.jpg) | Mixed |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45970/113237_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | ![](/images/96/1439_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5128/14084_A_7_2_rna_selected_60x60.jpg) | Group enriched |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32904/78602_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images/14067/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2494/6376_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/26761/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26761/56007_A_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20416/45830_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
EVI2B | Ecotropic viral integration site 2B | CD markers Predicted membrane proteins
| | ![](/images/53383/if_selected_60x60.jpg) | ![](/images/7436/ihc_cell_selected_60x60.jpg) | ![](/images/7436/19495_A_9_1_rna_selected_60x60.jpg) | Mixed |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | ![](/images/43616/if_selected_60x60.jpg) | | ![](/images/61700/138415_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/14050/32712_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10718/26352_B_9_3_rna_selected_60x60.jpg) | Mixed |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7796/18530_A_9_5_rna_selected_60x60.jpg) | Tissue enriched |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/55431/ihc_cell_selected_60x60.jpg) | ![](/images/32435/70987_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13323/30968_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4231/11727_B_1_8_rna_selected_60x60.jpg) | Tissue enriched |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_A_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images/13316/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2496/6299_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63182/142047_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GYPA | Glycophorin A (MNS blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/14811/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2658/6542_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |